The association between patients' perceived continuity of care and beliefs about oral anticancer treatment.
Administration, Oral
Adult
Antineoplastic Agents
/ administration & dosage
Continuity of Patient Care
/ statistics & numerical data
Cross-Sectional Studies
Depressive Disorder
Female
Health Knowledge, Attitudes, Practice
Humans
Male
Middle Aged
Neoplasms
/ drug therapy
Physicians, Primary Care
Surveys and Questionnaires
Beliefs about Medicines Questionnaire
Continuity of care
Nijmegen Continuity Questionnaire
Oral anticancer treatment
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
16
09
2018
accepted:
21
01
2019
pubmed:
29
1
2019
medline:
17
10
2019
entrez:
29
1
2019
Statut:
ppublish
Résumé
To explore factors associated with necessity beliefs and concerns among patients receiving oral anticancer therapy (OACT) and, specifically, to examine the relationship between continuity of care (COC) and patients' beliefs about OACT. A cross-sectional study was conducted among patients from four oncology centers receiving OACT (either targeted, hormonal, or chemotherapy). Two months after OACT initiation, patients were asked to participate in a face-to-face or telephone survey. The Beliefs about Medicines Questionnaire was used to examine patients' perceptions of their personal necessity for OACT and concerns about potential adverse effects. The Nijmegen Continuity Questionnaire was used to assess patients' perceived COC. Data on clinical characteristics were collected from medical records. Participants' beliefs about OACT necessity (n = 91) were found to be associated with COC within the oncology team, and with COC between the oncology specialist and the primary care physicians (β = 0.27, p = 0.003; β = 0.22, p = 0.02, respectively), beyond age, depression, and cancer type (ΔR This study shows that cancer patients' perceptions about the COC between care providers are related to their beliefs about OACT necessity, thus providing evidence for the importance of health care delivery approaches that support COC within the oncology team and between the oncology specialist and the primary care physician.
Identifiants
pubmed: 30689046
doi: 10.1007/s00520-019-04668-6
pii: 10.1007/s00520-019-04668-6
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
3545-3553Subventions
Organisme : Israel Cancer Association
ID : 20140089
Organisme : Israel National Institute for Health Policy Research
ID : 2015/84
Organisme : Maccabbi Healthcare Services
ID : 28/2016
Références
Timmers L, Beckeringh JJ, van Herk-Sukel MP, Boven E, Hugtenburg JG (2012) Use and costs of oral anticancer agents in the Netherlands in the period 2000–2008. Pharmacoepidemiol Drug Saf 21(10):1036–1044. https://doi.org/10.1002/pds.2225
doi: 10.1002/pds.2225
pubmed: 21956857
Schneider SM, Hess K, Gosselin T (2011) Interventions to promote adherence with oral agents. Semin Oncol Nurs 27(2):133–141. https://doi.org/10.1016/j.soncn.2011.02.005
doi: 10.1016/j.soncn.2011.02.005
pubmed: 21514482
pmcid: 3653175
Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15(1):110–115
doi: 10.1200/JCO.1997.15.1.110
pubmed: 8996131
Seal BS, Anderson S, Shermock KM (2016) Factors associated with adherence rates for oral and intravenous anticancer therapy in commercially insured patients with metastatic colon cancer. J Managed Care Specialty Pharm 22(3):227–235. https://doi.org/10.18553/jmcp.2016.22.3.227
doi: 10.18553/jmcp.2016.22.3.227
Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW (2007) Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA 297(8):831–841. https://doi.org/10.1001/jama.297.8.831
doi: 10.1001/jama.297.8.831
pubmed: 17327525
Ganesan P, Sagar TG, Dubashi B, Rajendranath R, Kannan K, Cyriac S, Nandennavar M (2011) Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia. Am J Hematol 86(6):471–474. https://doi.org/10.1002/ajh.22019
doi: 10.1002/ajh.22019
pubmed: 21538468
Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C (2013) Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer 108(7):1515–1524. https://doi.org/10.1038/bjc.2013.116
doi: 10.1038/bjc.2013.116
pubmed: 23519057
pmcid: 3629427
Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A (2013) Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treatment Rev 39(6):610–621. https://doi.org/10.1016/j.ctrv.2012.12.014
doi: 10.1016/j.ctrv.2012.12.014
Mathes T, Pieper D, Antoine SL, Eikermann M (2014) Adherence influencing factors in patients taking oral anticancer agents: a systematic review. Cancer Epidemiol 38:214–226. https://doi.org/10.1016/j.canep.2014.03.012
doi: 10.1016/j.canep.2014.03.012
pubmed: 24768601
Lin C, Clark R, Tu P, Bosworth HB, Zullig LL (2017) Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers. Breast Cancer Res Treatment 165(2):247–260. https://doi.org/10.1007/s10549-017-4317-2
doi: 10.1007/s10549-017-4317-2
Janz NK, Becker MH (1984) The health belief model: a decade later. Health Ed Quart 11(1):1–47. https://doi.org/10.1177/109019818401100101
doi: 10.1177/109019818401100101
Holmes EAF, Hughes DA, Morrison VL (2014) Predicting adherence to medications using health psychology theories: a systematic review of 20 years of empirical research. Value Health 17(8):863–876. https://doi.org/10.1016/j.jval.2014.08.2671
doi: 10.1016/j.jval.2014.08.2671
pubmed: 25498782
Lehane E, McCarthy G (2007) An examination of the intentional and unintentional aspects of medication non-adherence in patients diagnosed with hypertension. J Clin Nurs 16(4):698–706. https://doi.org/10.1111/j.1365-2702.2005.01538.x
doi: 10.1111/j.1365-2702.2005.01538.x
pubmed: 17402951
Gadkari AS, McHorney CA (2012) Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res 12:98. https://doi.org/10.1186/1472-6963-12-98
doi: 10.1186/1472-6963-12-98
pubmed: 22510235
pmcid: 3375198
Horne R, Weinman J (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47(6):555–567
doi: 10.1016/S0022-3999(99)00057-4
pubmed: 10661603
Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V (2013) Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One 8(12):e80633. https://doi.org/10.1371/journal.pone.0080633
doi: 10.1371/journal.pone.0080633
pubmed: 24312488
pmcid: 3846635
Foot H, La Caze A, Gujral G, Cottrell N (2016) The necessity-concerns framework predicts adherence to medication in multiple illness conditions: a meta-analysis. Patient Educ Couns 99(5):706–717. https://doi.org/10.1016/j.pec.2015.11.004
doi: 10.1016/j.pec.2015.11.004
pubmed: 26613666
Butler JA, Peveler RC, Roderick P, Smith PW, Horne R, Mason JC (2004) Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant 19(12):3144–3149. https://doi.org/10.1093/ndt/gfh505
doi: 10.1093/ndt/gfh505
pubmed: 15479748
Jacob Arriola KR, Mason TA, Bannon KA, Holmes C, Powell CL, Horne K, O’Regan R (2014) Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients. Patient Educ Couns 95(1):98–103. https://doi.org/10.1016/j.pec.2013.12.019
doi: 10.1016/j.pec.2013.12.019
pubmed: 24492157
Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R (2003) Continuity of care: a multidisciplinary review. BMJ 327(7425):1219–1221. https://doi.org/10.1136/bmj.327.7425.1219
doi: 10.1136/bmj.327.7425.1219
pubmed: 14630762
pmcid: 274066
Dossett LA, Hudson JN, Morris AM, Lee MC, Roetzheim RG, Fetters MD, Quinn GP (2017) The primary care provider (PCP)-cancer specialist relationship: systematic review and mixed-methods meta-synthesis. CA Cancer J Clin 67(2):156–169. https://doi.org/10.3322/caac.21385
doi: 10.3322/caac.21385
pubmed: 27727446
Uijen AA, Schers HJ, Schellevis FG, Mokkink HG, van Weel C, van den Bosch WJ (2012) Measuring continuity of care: psychometric properties of the Nijmegen Continuity Questionnaire. Br J Gen Pract 62(600):e949–e957. https://doi.org/10.3399/bjgp12X652364
doi: 10.3399/bjgp12X652364
pubmed: 22782001
pmcid: 3381279
Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD (2008) Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Int Med 23(3):254–259. https://doi.org/10.1007/s11606-007-0497-5
doi: 10.1007/s11606-007-0497-5
Husain A, Barbera L, Howell D, Moineddin R, Bezjak A, Sussman J (2013) Advanced lung cancer patients’ experience with continuity of care and supportive care needs. Support Care Cancer 21(5):1351–1358. https://doi.org/10.1007/s00520-012-1673-7
doi: 10.1007/s00520-012-1673-7
pubmed: 23274923
Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS, Leedy RD, Muller RJ, Newcomer LN, O’Brien S, Reinke D, Rubino M, Saltz L, Walters RS (2008) NCCN task force report: oral chemotherapy. J Natl Compr Cancer Netw 6(Suppl 3):S1–S14
Cohen J (1992) A power primer. Psychol Bull 112(1):155–159
doi: 10.1037/0033-2909.112.1.155
Channa Y, Shabo V (2012) Israel household expenditure survey and income survey 2010. Central Bureau of Statistics. http://www.cbs.gov.il/www/statistical/home10_e.pdf . Accessed 8 Sept 2018
Geulayov G, Jungerman T, Moses S, Friedman N, Miron R, Gross R (2009) Assessing the psychometric properties of the mood module of the Patient Health Questionnaire in primary care in Israel. Isr J Psychiatry Relat Sci 46:36
Bhattacharya D, Easthall C, Willoughby KA, Small M, Watson S (2012) Capecitabine non-adherence: exploration of magnitude, nature and contributing factors. J Oncol Pharm Pract 18(3):333–342. https://doi.org/10.1177/1078155211436022
doi: 10.1177/1078155211436022
pubmed: 22298660
Horne R, Weinman J, Hankins M (1999) The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 14(1):1–24. https://doi.org/10.1080/08870449908407311
doi: 10.1080/08870449908407311
Uijen AA, Schellevis FG, van den Bosch WJ, Mokkink HG, van Weel C, Schers HJ (2011) Nijmegen Continuity Questionnaire: development and testing of a questionnaire that measures continuity of care. J Clin Epidemiol 64(12):1391–1399. https://doi.org/10.1016/j.jclinepi.2011.03.006
doi: 10.1016/j.jclinepi.2011.03.006
pubmed: 21689904
Cohen Castel O, Dagan E, Keinan-Boker L, Shadmi E (2018) Reliability and validity of the Hebrew version of the Nijmegen Continuity Questionnaire for measuring patients’ perceived continuity of care in oral anticancer therapy. Eur J Cancer Care (Engl) 27(6):e12913. https://doi.org/10.1111/ecc.12913
doi: 10.1111/ecc.12913
Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613
doi: 10.1046/j.1525-1497.2001.016009606.x
pubmed: 11556941
pmcid: 1495268
Foglino S, Bravi F, Carretta E, Fantini MP, Dobrow MJ, Brown AD (2016) The relationship between integrated care and cancer patient experience: a scoping review of the evidence. Health Policy 120(1):55–63. https://doi.org/10.1016/j.healthpol.2015.12.004
doi: 10.1016/j.healthpol.2015.12.004
pubmed: 26712419
Komatsu H, Nakayama K, Togari T, Suzuki K, Hayashi N, Murakami Y, Iioka Y, Osaka W, Yagasaki K, Nakamura S, Neumann J, Ueno NT (2011) Information sharing and case conference among the multidisciplinary team improve patients’ perceptions of care. Open Nurs J 5:79–85. https://doi.org/10.2174/1874434601105010079
doi: 10.2174/1874434601105010079
pubmed: 22135715
pmcid: 3227867
Nielsen JD, Palshof T, Mainz J, Jensen AB, Olesen F (2003) Randomised controlled trial of a shared care programme for newly referred cancer patients: bridging the gap between general practice and hospital. Qual Saf Health Care 12(4):263–272
doi: 10.1136/qhc.12.4.263
pubmed: 12897359
pmcid: 1743735
Timmers L, Boons CC, Mangnus D, Van de Ven PM, Van den Berg PH, Beeker A, Swart EL, Honeywell RJ, Peters GJ, Boven E, Hugtenburg JG (2016) Adherence and patients’ experiences with the use of capecitabine in daily practice. Front Pharmacol 7:310. https://doi.org/10.3389/fphar.2016.00310
doi: 10.3389/fphar.2016.00310
pubmed: 27708578
pmcid: 5030243